M

Midland Florida Clinical Research Center, LLC | DeLand, FL

Research site
(Unclaimed)
Location
665 Peachwood Drive, DeLand, Florida, United States of America

Site insights

Top conditions

Top treatments

TAF
Emtricitabine
Bictegravir
Lenacapavir
Tenofovir Alafenamide
ABBV-382
GS-2872
Darunavir
Pritelivir
Obeldesivir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 18 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

The goal of this study is to test the effectiveness, safety, and tolerability of the combination of broadly neutralizing antibodies (bNAbs) (teropavi...

Active, not recruiting
HIV Infections
Drug: Lenacapavir Tablet
Drug: Zinlirvimab

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Enrolling
Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: ABBV-382

It is hypothesized that application at 4-week or greater intervals of the human placental umbilical cord tissue TTAX01 to the surface of a well debri...

Enrolling
Diabetic Foot Infection
Non-healing Wound
Biological: TTAX01
Other: Standard care

This is a pivotal Phase 2/3, double-blind, placebo-controlled study of epetraborole + OBR (Optimized Background Regimen) versus placebo + OBR in pati...

Active, not recruiting
MAC Lung Disease
Treatment Refractory MAC Lung Disease
Drug: Epetraborole
Drug: Placebo

This is a randomized, active-controlled, open-label study to assess the safety, tolerability and efficacy of Afabicin in the treatment of participant...

Enrolling
Bone or Joint Infection
Drug: Afabicin
Drug: Standard of Care

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling
HIV-1-infection
Drug: Stable Baseline Regimen
Drug: Bictegravir

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing re...

Active, not recruiting
HIV-1-infection
Drug: Optimized Background Regimen (OBR)
Drug: Failing ARV Regimen

Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or a...

Enrolling
HSV Infection
Drug: Investigator's choice
Drug: Pritelivir

Trial sponsors

Gilead Sciences logo
Pfizer logo
A
AbbVie logo
A
BeiGene logo
Debiopharm logo
Lilly logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems